The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer
 
Consulting or Advisory Role - Bayer
Speakers' Bureau - Intramed
Regorafenib for previously treated metastatic colorectal cancer (mCRC): A subgroup analysis of 364 patients in the USA treated in the international, open-label phase IIIb CONSIGN study.
 
Udit Verma
No Relationships to Disclose
 
Yull Edwin Arriaga
Consulting or Advisory Role - Bayer
 
Heinz-Josef Lenz
No Relationships to Disclose
 
Charles A. Henderson
No Relationships to Disclose
 
Jyotsna Fuloria
No Relationships to Disclose
 
Thomas H. Cartwright
Consulting or Advisory Role - Bayer; Genentech; Pfizer
Speakers' Bureau - Amgen; Astellas Pharma; Incyte; Johnson & Johnson; Lilly
Research Funding - Bayer
 
Ali Khojasteh
No Relationships to Disclose
 
Philip J. Stella
Employment - Physician Resource Management
Leadership - Physician Resource Management
Stock and Other Ownership Interests - Physician Resource Management
 
Marc Saltzman
Research Funding - Bayer; Cubist; Hospira; Merck
 
Allen Lee Cohn
Honoraria - Celgene; onyx; Sanofi
Speakers' Bureau - Celgene; Lilly; Sanofi
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
 
Christian Kappeler
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Joachim Kalmus
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
Speakers' Bureau - Genomic Health
 
Francis P. Arena
No Relationships to Disclose